{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T21:04:24Z","timestamp":1782421464954,"version":"3.54.5"},"reference-count":27,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Social and Administrative Pharmacy"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.sapharm.2019.05.002","type":"journal-article","created":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T19:39:45Z","timestamp":1557344385000},"page":"183-189","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["The uses and expenses of antihypertensive medications among hypertensive adults"],"prefix":"10.1016","volume":"16","author":[{"given":"Chanhyun","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guijing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boon Peng","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey M.","family":"Durthaler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carma","family":"Ayala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.sapharm.2019.05.002_bib1","first-page":"103","article-title":"Vital signs: prevalence, treatment, and control of hypertension--United States, 1999-2002 and 2005-2008","volume":"60","author":"Centers for Disease Control and Prevention","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"8","key":"10.1016\/j.sapharm.2019.05.002_bib2","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1161\/CIR.0b013e31820a55f5","article-title":"Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association","volume":"123","author":"Heidenreich","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.sapharm.2019.05.002_bib3","author":"Agency for Healthcare Research and Quality"},{"issue":"6","key":"10.1016\/j.sapharm.2019.05.002_bib4","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.HYP.0000107251.49515.c2","article-title":"Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure","volume":"42","author":"Chobanian","year":"2003","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.sapharm.2019.05.002_bib5","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1758-5996-2-44","article-title":"Combination therapy in hypertension: an update","volume":"2","author":"Kalra","year":"2010","journal-title":"Diabetol Metab Syndrome"},{"issue":"8","key":"10.1016\/j.sapharm.2019.05.002_bib6","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.amjhyper.2005.12.013","article-title":"Incremental expenditure of treating hypertension in the United States","volume":"19","author":"Balu","year":"2006","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.sapharm.2019.05.002_bib7","author":"Davis"},{"issue":"3","key":"10.1016\/j.sapharm.2019.05.002_bib8","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1177\/1524839907303794","article-title":"The economic burden of chronic cardiovascular disease for major insurers","volume":"8","author":"Trogdon","year":"2007","journal-title":"Health Promot Pract"},{"issue":"9246","key":"10.1016\/j.sapharm.2019.05.002_bib9","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1016\/S0140-6736(00)03307-9","article-title":"Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration","volume":"356","author":"Neal","year":"2000","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.sapharm.2019.05.002_bib10","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1093\/ajh\/hpt079","article-title":"Hypertension-associated expenditures for medication among US adults","volume":"26","author":"Wang","year":"2013","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.sapharm.2019.05.002_bib11","author":"U.S. Bureau of Economic Analysis (BEA)"},{"issue":"5","key":"10.1016\/j.sapharm.2019.05.002_bib12","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1055\/s-0038-1634956","article-title":"Risk adjustment in outcome assessment: the Charlson comorbidity index","volume":"32","author":"D'Hoore","year":"1993","journal-title":"Methods Inf Med"},{"issue":"21","key":"10.1016\/j.sapharm.2019.05.002_bib13","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1001\/jama.1997.03550210043036","article-title":"Trends in antihypertensive drug use in the United States: do the JNC V recommendations affect prescribing? Fifth joint national commission on the detection, evaluation, and treatment of high blood pressure","volume":"278","author":"Siegel","year":"1997","journal-title":"J Am Med Assoc"},{"issue":"4","key":"10.1016\/j.sapharm.2019.05.002_bib14","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1161\/01.HYP.36.4.600","article-title":"Trends in antihypertensive drug therapy of ambulatory patients by US office-based physicians","volume":"36","author":"Nelson","year":"2000","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.sapharm.2019.05.002_bib15","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1161\/HYPERTENSIONAHA.108.120154","volume":"53","author":"Muntner","year":"2009","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.sapharm.2019.05.002_bib16","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1161\/01.HYP.0000240931.90917.0c","article-title":"Changes in antihypertensive prescribing during US outpatient visits for uncomplicated hypertension between 1993 and 2004","volume":"48","author":"Ma","year":"2006","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.sapharm.2019.05.002_bib17","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1161\/01.HYP.0000229653.73128.b6","article-title":"Long-term and short-term changes in antihypertensive prescribing by office-based physicians in the United States","volume":"48","author":"Stafford","year":"2006","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.sapharm.2019.05.002_bib18","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jama.2013.284427","article-title":"2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)","volume":"311","author":"James","year":"2014","journal-title":"J Am Med Assoc"},{"issue":"17","key":"10.1016\/j.sapharm.2019.05.002_bib19","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1161\/CIRCULATIONAHA.112.096156","article-title":"Trends in antihypertensive medication use and blood pressure control among United States adults with hypertension: the National Health and Nutrition Examination Survey, 2001 to 2010","volume":"126","author":"Gu","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.sapharm.2019.05.002_bib20","doi-asserted-by":"crossref","first-page":"d4891","DOI":"10.1136\/bmj.d4891","article-title":"Management of hypertension: summary of NICE guidance","volume":"343","author":"Krause","year":"2011","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.sapharm.2019.05.002_bib21","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/MAJ.0000000000000308","article-title":"Racial differences in hypertension: implications for high blood pressure management","volume":"348","author":"Lackland","year":"2014","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.sapharm.2019.05.002_bib22","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/1471-2369-14-201","article-title":"Difference in blood pressure response to ACE-Inhibitor monotherapy between black and white adults with arterial hypertension: a meta-analysis of 13 clinical trials","volume":"14","author":"Peck","year":"2013","journal-title":"BMC Nephrol"},{"issue":"12","key":"10.1016\/j.sapharm.2019.05.002_bib23","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1093\/gerona\/gls148","article-title":"Management of hypertension in the elderly population","volume":"67","author":"Oliva","year":"2012","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"18","key":"10.1016\/j.sapharm.2019.05.002_bib24","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1001\/archinte.165.18.2098","article-title":"Racial disparities in hypertension prevalence, awareness, and management","volume":"165","author":"Hertz","year":"2005","journal-title":"Arch Intern Med"},{"issue":"1 Suppl 1","key":"10.1016\/j.sapharm.2019.05.002_bib25","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1524-6175.2006.05295.x","article-title":"Hypertension-related morbidity and mortality in African Americans--why we need to do better","volume":"8","author":"Ferdinand","year":"2006","journal-title":"J Clin Hypertens"},{"issue":"5","key":"10.1016\/j.sapharm.2019.05.002_bib26","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1161\/HYPERTENSIONAHA.110.152892","article-title":"Management of high blood pressure in Blacks: an update of the International Society on Hypertension in Blacks consensus statement","volume":"56","author":"Flack","year":"2010","journal-title":"Hypertension"},{"issue":"6S2","key":"10.1016\/j.sapharm.2019.05.002_bib27","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.1016\/j.amepre.2017.06.020","article-title":"Cost-effectiveness analyses of antihypertensive medicines: a systematic review","volume":"53","author":"Park","year":"2017","journal-title":"Am J Prev Med"}],"container-title":["Research in Social and Administrative Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741118310118?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741118310118?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T09:18:36Z","timestamp":1761556716000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551741118310118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S1551741118310118"],"URL":"https:\/\/doi.org\/10.1016\/j.sapharm.2019.05.002","relation":{},"ISSN":["1551-7411"],"issn-type":[{"value":"1551-7411","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The uses and expenses of antihypertensive medications among hypertensive adults","name":"articletitle","label":"Article Title"},{"value":"Research in Social and Administrative Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sapharm.2019.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}